Skip to main content

Norditropin News

FDA Medwatch Alert: Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death

[UPDATED 08/04/2011] FDA has determined that, at this time, the evidence regarding recombinant human growth hormone and increased risk of death is inconclusive. In its analysis of the SAGhE study, ...

Novo Nordisk Receives FDA Approval for Norditropin FlexPro for Growth Hormone Treatment

PRINCETON, N.J., March 3, 2010 /PRNewswire/ – Novo Nordisk announced today that the U.S. Food and Drug Administration (FDA) has approved Norditropin FlexPro (somatropin [rDNA origin] injection), a...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Norditropin patient information at Drugs.com